PharmTech Talk

Jan 04, 2016
More “me-betters” and more focused breakthroughs could enhance new drug development.
Dec 28, 2015
The FDA program that encourages biopharma companies to develop new treatments for rare and neglected diseases has been in the spotlight recently.
Dec 17, 2015
Janet Woodcock, director of the Center for Drug Evaluation, highlights FDA's priority list for 2016.
Dec 14, 2015
The use of drug compounding facilities to produce over-priced generic drugs raises quality and regulatory questions.
Dec 14, 2015
Pharmaceutical Technology
This month marks the death of a pragmatic, original thinker who helped make PAT and QbD a reality at more pharmaceutical facilities throughout the world.
Nov 26, 2015
Innovation and technology will be important differentiators for pharmaceutical companies trying to drive sustained growth in emerging markets.
Nov 24, 2015
Text from a merger prospectus reveals the termination fee for the proposed Pfizer-Allergan deal would change if any new tax regulations were passed prior to the closing of the transaction.
Nov 23, 2015
By Pharmaceutical Technology Editors
FDA emphasizes the surveillance aspects of quality metrics to concerned drug manufacturers.
Nov 18, 2015
Robert Califf addresses questions about drug pricing at the Senate hearing to weigh his appointment to be the next commissioner of FDA.
Nov 18, 2015
Experts at the ISPE annual meeting describe best practices, including containment and production in classified spaces.
native1_300x100
lorem ipsum